| __timestamp | Amicus Therapeutics, Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 21226345 |
| Thursday, January 1, 2015 | 76943000 | 87718074 |
| Friday, January 1, 2016 | 104793000 | 93831530 |
| Sunday, January 1, 2017 | 149310000 | 79419009 |
| Monday, January 1, 2018 | 270902000 | 132166913 |
| Tuesday, January 1, 2019 | 286378000 | 89124838 |
| Wednesday, January 1, 2020 | 308443000 | 65782137 |
| Friday, January 1, 2021 | 272049000 | 88845513 |
| Saturday, January 1, 2022 | 276677000 | 134715000 |
| Sunday, January 1, 2023 | 152381000 | 180142000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Amicus Therapeutics consistently outpaced Intra-Cellular Therapies in R&D spending, peaking in 2020 with a 548% increase from 2014. However, Intra-Cellular Therapies showed a remarkable 748% growth in the same period, surpassing Amicus in 2023. This shift highlights a strategic pivot by Intra-Cellular Therapies, emphasizing their growing focus on innovation.
These trends underscore the dynamic nature of the biotech industry, where strategic R&D investments can redefine market positions and drive future breakthroughs.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Amicus Therapeutics, Inc. vs Mesoblast Limited